<h4>Background</h4>Rheumatoid arthritis (RA) is typically preceded by an extended preclinical period where circulating autoantibodies, particularly anti-citrullinated protein antibodies (ACPA), are detectable in the absence of clinical arthritis. The gene discussed is PRTN3; the disease is rheumatoid arthritis.